HEMATOLOGIC MALIGNANCIES

Hematologic malignancies are neoplastic cancers that interfere with the production and function of blood cells in blood, bone marrow and lymph nodes. They include leukemias, lymphomas, myelomas, and are characterized by a wide spectrum of genetic and gene expression alterations.

Our genomic tests for different hematologic malignancies provide critical information for clinical diagnosis, subtype classification, risk stratification, drug resistance mechanisms and treatment decision-making. They also serve to monitor minimum residual disease, detect disease recurrence/resistance, and identify patients with the risk of disease recurrence after bone marrow transplantation by evaluating transplantation tolerance through hematopoietic chimerism.